原发性胆汁性胆管炎对英国患者生活质量及医疗费用的影响
该研究向英国PBC研究队列4583名参与者邮寄问卷,收集2015至2016年健康相关生活质量(HRQoL)与NHS资源使用数据,对2240名参与者进行计量经济学分析。发现PBC症状对HRQoL有显著影响,熊去氧胆酸治疗与更高HRQoL相关,肝移植史和腹水与HRQoL降低独立相关,肝移植(4294美元)和食管静脉曲张(3401美元)年均费用最高。
要点
- PBC症状对HRQoL有相当大的影响。
- 熊去氧胆酸治疗与显著更高的HRQoL相关,与应答状态无关。
- 肝移植史和腹水与HRQoL降低独立相关。
核心结论
- 对2240名英国PBC参与者的分析发现,HRQoL和费用估计能更深入了解PBC相关症状和并发症的相对重要性。
- 这些发现为PBC新疗法的卫生技术评估提供了估计值。
研究设计与样本
- 研究向英国PBC研究队列的4583名参与者邮寄问卷,收集2015至2016年HRQoL和NHS使用数据。
- HRQoL采用EQ-5D-5L工具测量,资源使用年费用采用NHS来源的单位成本计算。
- 采用计量经济学分析确定治疗、症状、并发症、肝移植状态和患者特征对HRQoL和年费用的影响。
- 分析纳入2240名参与者,超过英国所有PBC患者的10%。
主要发现
- PBC症状对HRQoL有相当大的影响。
- 熊去氧胆酸治疗与显著更高的HRQoL相关,与应答状态无关。
- 肝移植史和腹水与HRQoL降低独立相关。
- 肝移植(4294美元)和食管静脉曲张(3401美元)是NHS年均费用最高的两个因素。
- 症状与费用无独立关联,但与患者HRQoL降低相关,表明PBC症状缺乏有效治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: There have been few high-quality studies of the costs, preference-based health-related quality of life (HRQoL) and cost effectiveness of treatments for primary biliary cholangitis (PBC). We aimed to estimate the marginal effects of PBC complications and symptoms, accounting for treatment, on HRQoL and the annual cost of health care in the United Kingdom (UK). These are essential components for evaluation of cost effectiveness and this information will aid in evaluation of new treatments. METHODS: Questionnaires were mailed to 4583 participants in the UK-PBC research cohort and data were collected on HRQoL and use of the National Health Service (NHS) in the UK from 2015 through 2016. HRQoL was measured using the EQ-5D-5L instrument. The annual cost of resource use was calculated using unit costs obtained from NHS sources. We performed econometric analyses to determine the effects of treatment, symptoms, complications, liver transplantation status, and patient characteristics on HRQoL and annual costs. RESULTS: In an analysis of data from 2240 participants (over 10% of all UK PBC patients), we found that PBC symptoms have a considerable effect on HRQoL. Ursodeoxycholic acid therapy was associated with significantly higher HRQoL regardless of response status. Having had a liver transplant and ascites were also independently associated with reduced HRQoL. Having had a liver transplant (US$4294) and esophageal varices (US$3401) were the factors with the two greatest mean annual costs to the NHS. Symptoms were not independently associated with cost but were associated with reduction in HRQoL for patients, indicating the lack of effective treatments for PBC symptoms. CONCLUSIONS: In an analysis of data from 2240 participants in the UK PBC, we found that HRQoL and cost estimates provide greater insight into the relative importance of PBC-related symptoms and complications. These findings provide estimates for health technology assessments of new treatments for PBC.
引用
- Rice S, Albani V, Minos D, et al. Effects of Primary Biliary Cholangitis on Quality of Life and Health Care Costs in the United Kingdom. Clin Gastroenterol Hepatol. 2020. PMID: 32562892. doi:10.1016/j.cgh.2020.06.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。